Gain Therapeutics GANX
NASDAQ GANX
$1.29 +0.10 (+8.40%)
At close: Oct 22, 2026 · 4:00 PM EDT

Gain Therapeutics (GANX) Short-Term Debt repayments (2022 - 2026)

Updated

Gain Therapeutics (GANX) posted Short-Term Debt repayments of $25,297 for Q2 2026, up 4.4% from $24,238 a year earlier but down 0.9% from the prior quarter.

Analysis

Gain Therapeutics (GANX) Short-Term Debt repayments (2022 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Short-Term Debt repayments at Gain Therapeutics was $100,843, up 9.2% year-over-year; for FY2025, it came in at $96,501, up 6.2% from FY2024.

  • Annual Short-Term Debt repayments has increased for four consecutive years, with a four-year compound annual growth rate of 44.8% (FY2021 to FY2025).
  • In prior years, Gain Therapeutics' Short-Term Debt repayments was $90,879 in FY2024 (+2.0%), $89,067 in FY2023 (+13.1%), $78,774 in FY2022 (+258.9%) and $21,951 in FY2021.
  • Quarterly Short-Term Debt repayments has run from a low of -$1,363 in Q2 2022 to a high of $37,974 in Q1 2022 over five years.
  • On a year-over-year basis, Short-Term Debt repayments has increased in each of the last five quarters, with growth averaging 5.9% over the last eight quarters.
  • The strongest year-over-year quarter for Short-Term Debt repayments in the past five years was Q1 2026, with growth of 14.8%; the weakest was Q1 2023, with a decline of 43.1%.
  • According to Business Quant data, Short-Term Debt repayments for the three prior quarters was $25,525 (Q1 2026), $25,025 (Q4 2025) and $24,996 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ST Debt Repayment (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn -
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 6.63 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn -
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn -
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn -
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn -
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn -
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn -
10 Gain Therapeutics 54.89 Mn -4.40 Mn - 25,297.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 25,297.00
Mar 31, 2026 25,525.00
Dec 31, 2025 25,025.00
Sep 30, 2025 24,996.00
Jun 30, 2025 24,238.00
Mar 31, 2025 22,242.00
Dec 31, 2024 22,780.00
Sep 30, 2024 23,116.00
Jun 30, 2024 22,111.00
Mar 31, 2024 22,872.00
Dec 31, 2023 22,579.00
Sep 30, 2023 22,630.00
Jun 30, 2023 22,246.00
Mar 31, 2023 21,612.00
Dec 31, 2022 21,582.00
Sep 30, 2022 20,581.00
Jun 30, 2022 -1,363.00
Mar 31, 2022 37,974.00
API Access

Gain Therapeutics Short-Term Debt repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt-repayments&ticker=GANX&period=max&api_key=YOUR_API_KEY